• June 16-19, 2025
  • Boston Convention & Exhibition Center

amgen

 

PIONEERING PARTNERSHIPS

Genentech pioneered the biotech industry and continues to pursue revolutionary science and develop life-changing medicines to treat some of the world’s most complex health problems. As a member of the Roche Group, who has been innovating and redefining the standard of care for many devastating diseases for more than 125 years, together we are driving some of the most significant breakthroughs and reshaping treatment standards to help people with devastating diseases.

We are committed to developing life-altering scientific breakthroughs for people with difficult-to-treat diseases, but we cannot accomplish this on our own. By partnering with the brightest minds in science and healthcare, we have the potential to discover and develop ground-breaking treatments that can improve the lives of all patients.

 

Sabry

James Sabry

Global Head of Roche Pharma Partnering

“Working with us means working respectfully eye-to-eye with peers who share a passion for changing patients' lives through pioneering science and technology.”

 

Oncology & Cancer Immunotherapy

Oncology & Cancer Immunotherapy

Visali Ramanathan
Head of Business Development, Oncology, Genentech
Cardiovascular & Metabolic Disease, Immunology, and Infectious Diseases

Cardiovascular & Metabolic Disease, Immunology, and

Infectious Diseases

Enza di Modugno
Head of Immunology, CVM & Infectious Diseases, Pharma Partnering

Neuroscience, Ophthalmology, and Rare Diseases

Neuroscience, Ophthalmology, and

Rare Diseases

Tom Zioncheck
Head of Neuroscience, Ophthalmology and Rare Diseases, Pharma Partnering
Research Technologies

Research Technologies

Aly Jackson
Senior Manager, Business Development, Research Technologies

Digital & Personalized Healthcare

Digital & Personalized Healthcare

Grace Chen
Senior Director, Business Development, Digital & Personalized Healthcare
Roche Partnering Asia

Roche Partnering Asia

Harm-Jan Borgeld
Asia Partnering Head

Asset & Alliance Management

Asset & Alliance Management

Matthias Rueth
Asset & Alliance Management Head